Some patients find 1.0 mg or 1.7 mg weekly gives them good results, even though 2.4 mg is the target max for Wegovy
Potential Benefits Selective GH stimulation without cortisol, prolactin, or ACTH elevation at therapeutic doses: the defining clinical advantage over GHRP-6 and GHRP-2 Body composition support: GH-mediated fat oxidation and preservation of lean muscle mass, investigated in the context of age-related body composition changes Sleep quality improvement: Ipamorelin is typically dosed at bedtime to align with the natural nocturnal GH peak during slow-wave sleep, which may enhance sleep quality and recovery Bone density support: GH and downstream IGF-1 promote osteoblast activity and bone remodeling, relevant for patients with age-related bone density concerns Skin health and collagen synthesis: GH-mediated signaling supports dermal collagen production, investigated in the context of anti-aging skin applications Exercise recovery and protein synthesis: GH-mediated anabolic signaling supports muscle protein synthesis and recovery from physical training Energy and vitality: GH axis support in patients with age-related GH decline, investigated for improvements in energy, mood, and functional capacity Metabolic health: physician-supervised GH optimization may support insulin sensitivity and metabolic function in appropriate patient populations Anti-aging longevity applications: GH axis supplementation in patients with documented age-related secretory decline, as part of a comprehensive longevity protocol Synergistic combination with CJC-1295: the standard protocol pairs Ipamorelin (ghrelin receptor) with CJC-1295 (GHRH receptor) for greater GH release than either peptide produces alone Speak with a physician Interested in Ipamorelin
Exponentially slower than reconstituted peptides, which lose 2035% potency in the same timeframe
Studies demonstrate its ability to stimulate cell migration and tendon fibroblast activity, leading to improved tendon outgrowth and repair, particularly in injuries like Achilles tendon ruptures (2)
